(NasdaqGM:RCKT), NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline. SO WHAT: If […]

RCKT DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class Action – RCKT GlobeNewswire August 10, 2025 NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your XPLR Infrastructure, LP f/k/a Nextera Energy Partners, LP (NYSE:XIFR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/xplr-infrastructure-lp-f-k-a-nextera-energy-partners-lp-lawsuit-submission-form?prid=160673&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Confluent, Inc. ("Confluent, Inc.") (NASDAQ:CFLT) concerning possible violations of federal securities laws. Confluent issued a press release on July 30, 2025, announcing its financial results for the second quarter of 2025 and

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inspire Medical Systems, Inc. ("Inspire Medical Systems, Inc.") (NYSE:INSP) concerning possible violations of federal securities laws. On August 5, 2025, Inspire issued a press release announcing better-than-expected second quarter fiscal 2025 results,

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Anika Therapeutics, Inc. ("Anika Therapeutics, Inc.") (NASDAQ:ANIK) concerning possible violations of federal securities laws. Anika issued a press release on July 30, 2025, "announc[ing] topline results from its U.S. pivotal clinical trial

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=160676&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Biohaven Ltd. (NYSE:BHVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biohaven-ltd-lawsuit-submission-form?prid=160677&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Insperity, Inc. ("Insperity, Inc.") (NYSE:NSP) concerning possible violations of federal securities laws. Insperity issued a press release on August 1, 2025, announcing its financial results for the second quarter of 2025. Among

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tronox Holdings plc ("Tronox Holdings plc") (NYSE:TROX) concerning possible violations of federal securities laws. Tronox issued a press release on July 30, 2025, reporting its financial results for the second quarter of